Nurse Practitioner in Moon Twp, PA Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Ms. Nancy Lee Yost, CRNP Nurse Practitioner - Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 927 Brodhead Rd, Moon Twp, PA 15108 Phone: 412-264-7205 Fax: 412-264-7790 |
News Archive
Consensus paper on atrial cardiomyopathies could be important step forward for research, treatment
The first consensus paper on atrial cardiomyopathies is set to be published simultaneously in EP-Europace, HeartRhythm, and the Journal of Arrhythmia. The key contents are launched today at CARDIOSTIM - EHRA EUROPACE 2016.
IDRI receives $1 million RHSC grant to eliminate leprosy
Leprosy, otherwise referred to as Hansen's Disease, is one of the most ancient diseases known to humans. Although the World Health Organization declared leprosy to be under control in many previously endemic countries, most experts agree that current approaches to treating the disease are not sufficient to eliminate the disease as a public health problem. Currently, 1.6 billion people are considered at risk of exposure to leprosy, while over 800 new cases occur every day.
Cancer patients who miss scheduled radiation therapy appointments have worse outcomes
Cancer patients who miss two or more radiation therapy sessions have a worse outcome than fully compliant patients, investigators at Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine's NCI-designated Albert Einstein Cancer Center have found.
Saturday night vote set on house health reform
The Washington Post reports: "Democratic whips worked their rank and file, while House leaders tried to secure a momentum-building endorsement from the AARP, the nation's largest association of people over 50. President Obama, meanwhile, laid plans to visit Capitol Hill on Thursday or Friday to address House Democrats in a final push for his signature domestic initiative.
Norgine to develop and commercialize Tranzyme's ulimorelin ghrelin agonist
Tranzyme Pharma, a clinical-stage biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, announced today that they have entered into a licensing agreement that provides Norgine with the exclusive rights to develop and commercialize Tranzyme's novel ghrelin agonist, ulimorelin (TZP-101), in Europe, Australia, New Zealand, the Middle East, South Africa and North Africa. Ulimorelin is entering Phase 3 development for the treatment of gastrointestinal dysmotility conditions in acute care settings.
› Verified 5 days ago